Head of Clinical Biomarkers, West Coast Hub

Role Summary

Head of Clinical Biomarkers, West Coast Hub – lead the Clinical Biomarkers function for a portfolio of investigational therapeutics across late stage research, early development, and late/registrational clinical development. Senior leadership role responsible for strategic direction, oversight, and portfolio-wide advancement of the clinical biomarkers pillar. Manage a team of Biomarker and Bioanalytical scientists and collaborate with Biogen leaders across Research, Development, and Commercial.

Responsibilities

• Define and lead the strategy for clinical biomarker development across the WCH portfolio, ensuring alignment with enterprise goals and therapeutic area priorities
• Serve as a key member of the WCH Biomarker and Clinical Pharmacology leadership team and WCH Development Extended Leadership Team
• Serve as a key thought leader and decision-maker in biomarker strategy, influencing cross-functional and cross-portfolio initiatives
• Oversee design, implementation, and execution of biomarker strategies for WCH clinical programs, ensuring scientific rigor, innovation, and regulatory readiness from Phase 1 through pivotal studies
• Drive and support indication expansion and lifecycle management through translational biomarker insights and integrated development planning
• Recruit, lead, and develop a high-performing, diverse team of Biomarker leads and Biomarker/Bioanalytical scientists
• Mentor and develop biomarker talent, ensuring succession planning and career growth
• Serve as the key biomarker liaison with research, clinical development, regulatory, medical affairs, and commercial functions to drive alignment
• Lead biomarker development initiatives for the WCH, ensuring translation into clinical programs
• Lead strategic partnerships with academic institutions, external partners, and consortia to advance biomarker science
• Ensure resource allocation, budget management, and operational execution of biomarker projects, including outsourced activities
• Author and review key scientific, regulatory, and clinical documents
• Drive biomarker publication strategy and represent Biogen in external forums and regulatory engagements
• Champion adoption and integration of cutting-edge biomarker technologies
• Evaluate emerging methodologies and platforms to enhance biomarker capabilities

Qualifications

• PhD or MD/PhD in a relevant field with 15+ years of leadership experience in biomarker development
• Proven track record of strategic leadership and delivery of biomarker strategies across multiple therapeutic areas
• Extensive experience leading Director-level and above professionals, with talent development and organizational scaling
• Exceptional executive communication and influence skills with senior stakeholders
• Deep expertise in clinical development, regulatory strategy, translational science, and life cycle management
• Ability to drive cross-functional alignment across R&D and commercial functions
• Advanced knowledge of biomarker technologies (cytometry, immunoassay, genomics) and clinical applications
• Recognized thought leader with external presence in regulatory, academic, and industry forums
• Experience in B cell immunology, nephrology, and/or solid organ transplant is highly desirable

Education

• PhD or MD/PhD in a relevant scientific field

Additional Requirements

• None beyond those listed in Qualifications